X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - PHARMABIZ.COM - A la Une - 20/Jun 00:00

Aethlon Medical receives HREC's approval for Hemopurifier cancer trial

Aethlon Medical, Inc., a medical therapeutic company focused on developing products to treat cancer and life─threatening infectious diseases, announced that the Human Research Ethics Committee (HREC)

Articles similaires

Sorry! Image not available at this time

CDR─Life expands pipeline of highly cancer─specific targeted therapies

pharmabiz.com - 27/Jun 00:00

CDR─Life Inc, a global company developing powerful T─cell engagers (TCE) to eradicate hard─to─treat solid tumors, has announced an expansion...

Sorry! Image not available at this time

Phase 1 Clinical Trial of PMC-403 for Neovascular Age-related Macular Degeneration Advances to Both Single-dose of 4mg and Multiple-dose of 3mg

drugs.com - 02/Jul 04:07

DAEJEON, South Korea, July 2, 2024. PharmAbcine, Inc. ("PharmAbcine" or the "Company") (KOSDAQ: 208340), a clinical-stage public company developing...

Sorry! Image not available at this time

Cartesian Therapeutics doses first patient in phase 2 clinical trial of Descartes─08 to treat systematic lupus erythematosus

pharmabiz.com - 00:00

Cartesian Therapeutics, Inc, a clinical─stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, announced that the first...

Sorry! Image not available at this time

SpringWorks Therapeutics Completes Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN

drugs.com - 01/Jul 06:07

STAMFORD, Conn., July 01, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused...

Sorry! Image not available at this time

Synaptogenix gets US FDA authorization of IND application for clinical trial for Bryostatin─1 to treat multiple sclerosis

pharmabiz.com - 01/Jul 00:00

Synaptogenix, Inc., an emerging biopharmaceutical company developing therapeutics for neurodegenerative disorders, announced that the Food & Drug...

Sorry! Image not available at this time

First Patient Dosed in the MAD Part 2 Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity

drugs.com - 26/Jun 19:06

CAMBRIDGE, Mass., June 26, 2024. NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on transforming cardiometabolic...

Sorry! Image not available at this time

University of Nebraska Medical Center enrolls patient for RenovoRx's pivotal phase III TIGeR─PaC trial

pharmabiz.com - 28/Jun 00:00

RenovoRx, Inc, a clinical─stage biopharmaceutical company developing novel precision oncology therapies based on a local drug─delivery platform,...

Sorry! Image not available at this time

Liver Institute serves 452,657 citizens in 5 months

dailynewsegypt.com - 22/Jun 20:20

Egypt’s Ministry of Health and Population announced that 452,657 citizens received medical services, through the National Institute for Research on...

Sorry! Image not available at this time

First Patient Dosed in Phase 2 Trial of Descartes-08 in Systematic Lupus Erythematosus

drugs.com - 03/Jul 04:07

GAITHERSBURG, Md., July 02, 2024. artesian Therapeutics, Inc. (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell...

Sorry! Image not available at this time

NIH-Sponsored Trial of Enterovirus D68 Therapeutic Begins

drugs.com - 27/Jun 06:07

June 27, 2024 -- The National Institutes of Health (NIH) is sponsoring a clinical trial to evaluate the safety of an investigational monoclonal...

Les derniers communiqués

  • Aucun élément